ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
Tevogen Bio Holdings Inc

Tevogen Bio Holdings Inc (TVGN)

1.38
0.00
(0.00%)
終了 1月24日 6:00AM
0.00
0.00
(0.00%)
取引時間後: -

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

主要統計と詳細

通貨
1.38
買値
1.38
売値
1.40
出来高
-
0.00 日の範囲 0.00
0.2556 52 週間の範囲 21.09
時価総額
前日終値
1.38
始値
-
時刻
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
2,553,024
発行済株式数
175,051,247
配当利回り
-
PER
-11,275.00
1 株当たり利益 (EPS)
-0
歳入
-
純利益
-67k

Tevogen Bio Holdings Inc について

Tevogen Bio is a leading NextGen clinical-stage specialty immunotherapy Biotech developing off-the-shelf precision T cell therapeutics in virology, oncology, and neurology. Tevogen Bio is a leading NextGen clinical-stage specialty immunotherapy Biotech developing off-the-shelf precision T cell therapeutics in virology, oncology, and neurology.

セクター
Biological Pds,ex Diagnstics
業界
Blank Checks
ウェブサイト
本社
Wilmington, Delaware, USA
設立
2024
Tevogen Bio Holdings Inc is listed in the Biological Pds,ex Diagnstics sector of the ナスダック市場 with ticker TVGN. The last closing price for Tevogen Bio was US$1.38. Over the last year, Tevogen Bio shares have traded in a share price range of US$ 0.2556 to US$ 21.09.

Tevogen Bio currently has 175,051,247 shares in issue. The market capitalisation of Tevogen Bio is US$241.57 million. Tevogen Bio has a price to earnings ratio (PE ratio) of -11275.00.

TVGN 最新ニュース

Tevogen Bio Highlights the Future of AI-Driven Drug Development in Fireside Chat with Microsoft During the J.P. Morgan Healthcare Conference

WARREN, N.J., Jan. 23, 2025 (GLOBE NEWSWIRE) -- Tevogen Bio Holdings Inc. (“Company” or “Tevogen Bio”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio to Host Panel Discussions “AI In Biopharma: Next Frontier of Medical Innovation” and “Pioneering the Economics of Health: Balancing Access and Outcomes” During J.P. Morgan Healthcare Conference

The JPM Healthcare Conference is the largest and most informative health care investment symposium in the industry which connects global industry leaders, emerging fast-growth companies...

Tevogen Bio to Host Panel "AI In Biopharma: Next Frontier of Medical Innovation" During the 43rd Annual J.P. Morgan Healthcare Conference

WARREN, N.J., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio Strengthens Robust IP Portfolio With Filing of Predictive AI Patent, With the Goal to Establish a Blueprint to Unlock the Full Potential of T Cell Therapies and Accelerate AI Integration to Advance Its Bold Growth Agenda

WARREN, N.J., Dec. 19, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio to Host Panel “Pioneering the Economics of Health: Balancing Access and Outcomes” During the 43rd Annual J.P. Morgan Healthcare Conference

WARREN, N.J., Dec. 17, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio to Attend the 43rd Annual J.P. Morgan Healthcare Conference

WARREN, N.J., Dec. 10, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Dr. Ryan Saadi Commends Individuals Who Dedicate Time to Public Service, and Congratulates Mayor Victor Sordillo on His Induction Into the NJ League of Municipalities Hall of Fame

WARREN, N.J., Dec. 05, 2024 (GLOBE NEWSWIRE) -- Dr. Ryan Saadi, CEO of Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech...

Tevogen Bio Prepares Organizational Readiness to Support Company’s Growth Strategy

WARREN, N.J., Nov. 26, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio CEO Reflects on Public Support, Reaffirms Preserving Shareholder Value Remains His Priority, and Reinforces Options Including a Potential Share Buyback to Support Company Value

WARREN, N.J., Nov. 21, 2024 (GLOBE NEWSWIRE) -- Tevogen Bio (“Tevogen” or “Tevogen Bio Holdings Inc.”) (Nasdaq: TVGN), a clinical-stage specialty immunotherapy biotech developing off-the-shelf...

Tevogen Bio Reports Third Quarter 2024 Financial Results; Highlights Significantly Improved Financial Position, Unreported Asset Value on Balance Sheets, Efficient Business Model

Improved operating performance by reducing net loss by $52.5 million; reported net loss of $4.3 million and $56.8 million for the nine months ended September 30, for 2024 and 2023...

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.1512.19512195121.231.381.2058753601.31784059CS
40.3432.69230769231.041.570.989114423821.28444724CS
12-1.08-43.90243902442.462.63530.856525530241.39000402CS
260.6589.04109589040.733.090.255686694311.53876131CS
52-2.72-66.34146341464.121.090.255649478051.54883063CS
156-2.72-66.34146341464.121.090.255649478051.54883063CS
260-2.72-66.34146341464.121.090.255649478051.54883063CS

TVGN - Frequently Asked Questions (FAQ)

What is the current Tevogen Bio share price?
The current share price of Tevogen Bio is US$ 1.38
How many Tevogen Bio shares are in issue?
Tevogen Bio has 175,051,247 shares in issue
What is the market cap of Tevogen Bio?
The market capitalisation of Tevogen Bio is USD 241.57M
What is the 1 year trading range for Tevogen Bio share price?
Tevogen Bio has traded in the range of US$ 0.2556 to US$ 21.09 during the past year
What is the PE ratio of Tevogen Bio?
The price to earnings ratio of Tevogen Bio is -11.28k
What is the reporting currency for Tevogen Bio?
Tevogen Bio reports financial results in USD
What is the latest annual profit for Tevogen Bio?
The latest annual profit of Tevogen Bio is USD -67k
What is the registered address of Tevogen Bio?
The registered address for Tevogen Bio is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801
What is the Tevogen Bio website address?
The website address for Tevogen Bio is www.tevogen.com/
Which industry sector does Tevogen Bio operate in?
Tevogen Bio operates in the BLANK CHECKS sector

ムーバー

すべて表示
  • 出来高
  • 値上がり率
  • 値下がり率
銘柄コード株価出来高
AALAmerican Airlines Group Inc
US$ 17.03
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.26
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.03
(0.00%)
0
AACGATA Creativity Global
US$ 0.9128
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.03
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.26
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.03
(0.00%)
0
AACGATA Creativity Global
US$ 0.9128
(0.00%)
0
AALAmerican Airlines Group Inc
US$ 17.03
(0.00%)
0
AAGRAfrican Agriculture Holdings Inc
US$ 0.1326
(0.00%)
0
AADRAdvisorShares Dorsey Wright ADR ETF
US$ 74.26
(0.00%)
0
AADIAadi Bioscience Inc
US$ 3.03
(0.00%)
0
AACGATA Creativity Global
US$ 0.9128
(0.00%)
0

TVGN Discussion

投稿を表示

最近閲覧した銘柄

Delayed Upgrade Clock